Maria-Victoria Mateos
玛丽亚-维多利亚·马特奥斯
MD, PhD
Head of Hematology Department and Multiple Myeloma Unit血液学科及多发性骨髓瘤单元主任
👥Biography 个人简介
Dr. Maria-Victoria Mateos is a leading European myeloma expert renowned for her work on daratumumab-based combination therapies and smoldering myeloma intervention. She has led pivotal GEM (Spanish Myeloma Group) trials redefining frontline and maintenance treatment strategies in myeloma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Daratumumab Combination Regimens
Designed and led ALCYONE and MAIA trials establishing daratumumab plus VMP and daratumumab plus Rd as standard-of-care frontline regimens for transplant-ineligible myeloma patients.
Smoldering Myeloma Treatment
Conducted the landmark QuiRedex trial demonstrating that early intervention in high-risk smoldering myeloma with lenalidomide-dexamethasone delays progression to symptomatic disease.
Representative Works 代表性著作
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
New England Journal of Medicine (2018)
ALCYONE trial showing daratumumab combination significantly improved PFS in transplant-ineligible newly diagnosed myeloma.
Treatment of High-Risk Smoldering Myeloma
New England Journal of Medicine (2013)
QuiRedex trial demonstrating early treatment delays progression and improves overall survival in high-risk smoldering myeloma.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Elihu Estey
Fred Hutchinson Cancer Center
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Naval Daver
The University of Texas MD Anderson Cancer Center
Courtney DiNardo
The University of Texas MD Anderson Cancer Center
关注 玛丽亚-维多利亚·马特奥斯 的研究动态
Follow Maria-Victoria Mateos's research updates
留下邮箱，当我们发布与 Maria-Victoria Mateos（University Hospital of Salamanca, IBSAL）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment